Biomark Diagnostics Ratios and Metrics

Market cap in millions CAD. Fiscal year is April - March.

Millions CAD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	49	22	25	15	16	31
Market Cap Growth	192.31%	-9.92%	60.95%	-1.62%	-48.77%	128.35%
Enterprise Value	48	24	26	17	17	31
Last Close Price	0.50	0.27	0.30	0.21	0.23	0.42
PS Ratio	393.44	145.04	152.12	100.50	356.91	-
PB Ratio	56.24	12.85	-40.73	-13.42	-24.67	-386.98
P/TBV Ratio	56.24	12.85	-	-	-	-
EV/Sales Ratio	-	154.52	161.35	110.73	393.16	-
Debt / Equity Ratio	0.93	0.64	-2.54	-1.44	-3.09	-12.70
Asset Turnover	0.09	0.07	0.18	0.14	0.04	-
Quick Ratio	1.73	2.14	0.16	0.06	0.31	0.98
Current Ratio	1.73	2.14	0.16	0.08	0.33	1.00
Return on Equity (ROE)	-	-340.70%	-	-	-	-
Return on Assets (ROA)	-79.14%	-60.59%	-117.29%	-104.38%	-66.20%	-80.77%
Return on Capital Employed (ROCE)	-197.50%	-107.60%	1099.30%	197.40%	4328.70%	-3366.60%
Earnings Yield	-3.41%	-8.62%	-5.75%	-11.94%	-9.27%	-3.57%
FCF Yield	-2.93%	-4.90%	-3.98%	-5.96%	-8.06%	-2.64%
Buyback Yield / Dilution	-10.10%	-6.67%	-2.97%	-6.22%	-6.31%	-2.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.